Molecular Biology and New Therapeutic Approaches to Cancer

Dear Colleagues,

Cancer continues to pose a growing global health problem and is the second leading cause of death worldwide. Cancer is a heterogeneous group of malignancies with different prognosis and treatment considerations. This Special Issue aims to compile the latest advances in our understanding of cancer at the molecular level and to explore novel therapeutic strategies aimed at improving patient outcomes.

We encourage the submission of both review articles and original research papers (basic research and translational research) that highlight new therapeutic modalities, new drug leads and novel compounds, including targeted therapies, immunotherapies, and precision medicine approaches tailored to individual patients based on their molecular profiles. 

We also welcome contributions that shed light on the intricate molecular pathways underlying cancer initiation, progression and metastasis, including current therapeutic challenges such as cancer cell drug resistance. This Special Issue also aims to address the dynamic interplay between components of the tumor microenvironment and cancer cell behavior at the molecular level to identify novel biomarkers and therapeutic targets.

Dr. Martin Vojtek
Dr. Carmen Diniz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer
• biomarkers
• therapy
• pharmacology
• tumor environment
• in vivo
• in vitro